Deal Announcements

AnaptysBio Secures $8 Million Venture Capital Funding

Tuesday, October 18, 2011 5:37:00 AM PDT | VentureDeal Staff

   San Diego, California  --  Biotechnology company AnaptysBio has received $8 million in venture capital equity financing, according to an SEC regulatory filing.

AnaptysBio says that it is developing somatic hypermutation for antibody discovery and optimization.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

AnaptysBio is still seeking an additional $13.9 million in financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1